NCT05602025 - A Study to Compare the Pharmacokinetics (PK) of Depemokimab When Delivered With a Safety Syringe Device (SSD) or an Autoinjector in Healthy Adult Participants | Biotech Hunter

Enrollment

140

Participants

Timeline

Start Date

December 13, 2022

Primary Completion Date

October 23, 2023

Study Completion Date

October 23, 2023

Conditions

Asthma

Interventions

BIOLOGICAL

Depemokimab

Depemokimab will be administered via a SSD or autoinjector.

Trial Locations (3)

GSK Investigational Site, Orlando

GSK Investigational Site, Austin

GSK Investigational Site, Las Vegas